Cambridge Epigenetix is a DNA sequencing tools and technology company that powers early diagnosis of cancer and monitoring of disease. Its unique technology enables the identification of the four genetic bases as well as two additional epigenetic letters from small DNA samples in a single workflow with high accuracy.
Milestones
- Founded 2012
- Partnered 2016
Team
- Peter Fromen
- Shankar Balasubramanian
- Bobby Yerramilli-Rao